| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |